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ABSTRACTSBackground: Both orthopaedic surgery and cast immobilisation are
independent risk factors for development of VTE1. There are currently no
guidelines on appropriate risk stratiﬁcation or treatment for this cohort of
patients2. The potentially signiﬁcant ﬁnancial cost of prophylaxis has
previously not been established.
Aims: To perform an economic analysis to determine the potential costs
and beneﬁts of the above treatment.
Methods: Data from one hundred patients who had undergone lower limb
immobilisation were prospectively collected using a specially designed
proforma. Information included personal demographics, diagnosis and
adjusted risk factors for VTE.
A decision tree model from a NHS perspective was used to calculate both
cost of prophylaxis and cost of VTE diagnosis, treatment and long term
complications. Incremental cost-effectiveness ratios (ICER) were calcu-
lated to provide estimates of the cost per VTE averted, and cost per quality-
adjusted life year (QALY) gained with the use of thromboprophylaxis.
Discussion 46/100 patients with primary lower limb cast immobilisation
qualiﬁed for prophylaxis. This numberof patientswould incur a prophylaxis
cost of £9113.52, however would save an estimated £3617.44 in direct VTE
diagnosis and treatment costs and £19,847.10 in long-term costs. This
resulted in a cost per VTE averted of £3338.10 and cost perQALYof £9623.58.
There are substantial cost implications in using thromboprophylaxis for
cast immobilised patients, however it has been demonstrated that this
may be cost effective in the long term. Using a more selective risk strati-
ﬁcation tool may reduce direct prophylaxis costs and increase short term
cost effectiveness.
SYMPTOMS SUGGESTIVE OF DUMPING SYNDROME AFTER PROVOCATION
IN PATIENTS AFTER LAPAROSCOPIC SLEEVE GASTRECTOMY
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Background: Dumping syndrome is a well-known complication after
upper gastrointestinal (GI) surgery. There are scarce data in the literature
about the incidence of dumping after bariatric operations but, certainly no
relation between this syndrome and laparoscopic sleeve gastrectomy
(LSG) has been attempted.
Methods: We conducted a prospective clinical study in order to evaluate
the potential presence, incidence and severity of Dumping syndrome after
LSG. Thirty one non-diabetic morbidly obese patients (eight male, 23
female) eligible for LSG were evaluated. Median age was 38 (22e58 years)
and mean body mass index (BMI) was 45.55 (5.37). The diagnosis of
dumping syndrome was based on clinical provocation of signs and
symptoms using an oral glucose challenge before and 6 weeks after the
operation. The Sigstad's dumping score was estimated in order to separate
dumpers from non-dumpers, and the Arts questionnaire was completed to
distinguish between early and late dumping. Moreover, blood glucose
levels during the oral glucose challenge were measured.
Results: No patient had symptoms of dumping after provocation preop-
eratively, whereas after LSG 9 patients (29%) experienced deﬁnite
dumping and other 5 patients (16%) symptoms suggestive of dumping
syndrome. Arts’ questionnaire demonstrated that dumping occurrence
after LSG was associated with early symptoms. Late hypoglycaemia
occurred in one patient.
Conclusion: A signiﬁcant proportion of patients after LSG experienced
dumping syndrome upon provocation. It seems that LSG should no longer
be considered as a pure restrictive procedure, and it might be an option for
heavy sweeters by changing their food tolerance patterns.
APPEARANCES CAN BE DECEIVING e GENETIC HETEROGENEITY IN THE
COLON OF CANCER PATIENTS
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Background: Distinct histological features physically deﬁne a colorectal
carcinoma (CRC) and distinguish it from the normal colon mucosa. Often,however, there are regions adjacent to a carcinoma that deviate from the
normal histological appearance and display features of hyperplasia and/or
adenoma. It is not certain whether these regions represent precursor
lesions or reactive changes. To address this we have characterised a series
copy number alterations (CNAs) that typify CRC in the regions adjacent to
a carcinoma.
Methods: Micro-dissection molecular copy number counting (mMCC) was
used to assay CNAs frequently observed in CRC and those known to
contribute to carcinogenesis. mMCC employs laser capture micro-dissec-
tion to accurately collect DNA from speciﬁc histological regions and uses
single molecule digital PCR to measure copy number. Four CRC cases were
characterised.
Results: In the normal colon we describe genetic heterogeneity and
identify CNAs that are known to contribute to tumour formation, namely
KRAS ampliﬁcation. In addition a number of copy number changes are
shared by and built on in the hyperplastic, adenomatous and carcinoma
samples.
Conclusion: These preliminary data support the model of step-wise
cancer progression but importantly suggest that nearby hyperplastic
regions may represent precursors rather than reactive changes. These
results have implications on our understanding of CRC pathogenesis and
practically on the optimal location of resection boundaries in CRC surgery.
Further work is now needed to establish how widespread CNAs are in the
normal colon and regions adjacent to CRC.
THE QUALITY OF REPORTING IN RANDOMISED CONTROLLED TRIALS IN
PLASTIC SURGERY
Eric Edison. UCL Medical School, United Kingdom
Introduction: Randomised controlled trials (RCTs) represent the gold
standard in evaluating healthcare interventions. However, RCTs can yield
biased results if they lack methodological rigour, especially where surgical
techniques are involved. Readers need complete, clear and transparent
information. The Consolidated Standards of Reporting Trials (CONSORT)
statement for non-pharmacological interventions was developed to aid
reporting and consists of a 23 essential items.
Aim: To assess the compliance of RCTs in Plastic Surgery with the
CONSORT statement.
Method: Medline was searched by an information specialist from 1
January 2009 to 30 June 2011 for the MESH heading “Surgery, Plastic” with
limitations for English language, human studies and randomised
controlled trials. Results were then manually searched for relevant RCTs
involving surgical techniques. These were scored against the 23 item
CONSORT checklist. Secondary scoring was then performed and discrep-
ancies resolved by consensus.
Results: 55 papers involving 3,830 patients met the inclusion criteria from
a manual search of 254 papers retrieved from Medline. The average
CONSORT score was 11.5 out of 23 items (50%, range 5.3e21.0). Compliance
was poorest with items related to intervention/comparator details (7%),
randomisation implementation (11%) and blinding (26%). There was no
link between journal 2010 impact factor and CONSORT score (R ¼ 0.25).
Only 60% declared conﬂicts of interest and 75% had permission from an
ethics committee.
Conclusion: The reporting quality of RCTs in Plastic Surgery is poor.
Importantly, those aspects central to RCT methodology (randomisation
and blinding) were the most poorly reported.
FUNCTIONAL HEALTH STATUS OF PATIENTS AFTER THE FONTAN
OPERATION
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Background: The Fontan procedure is a palliative procedure for the single
ventricle, existing for about four decades. A retrospective study was made
